论文部分内容阅读
目的:探讨阿莫西林联合果胶铋治疗慢性萎缩性胃炎患者的效果。方法:选取我科2014年3月至2015年9月期间收治的52例慢性萎缩性胃炎患者,采用数字单双号的模式分为对照组(单用阿莫西林)与治疗组(阿莫西林联合果胶铋),每组各26例。比较两组患者的临床疗效与不良反应发生率。结果:治疗组患者的治疗总有效率与不良反应发生率均显著优于对照组患者。结论:针对慢性萎缩性胃炎患者,通过阿莫西林联合果胶铋治疗可以显著改善患者的临床症状,能够提升临床疗效,降低不良反应发生率,值得临床推广应用。
Objective: To investigate the effect of amoxicillin combined with pectin bismuth in patients with chronic atrophic gastritis. Methods: A total of 52 patients with chronic atrophic gastritis who were treated in our department from March 2014 to September 2015 were selected and divided into control group (amoxicillin alone) and treatment group (amoxicillin alone) Joint pectin bismuth), each group of 26 cases. The clinical efficacy and incidence of adverse reactions in the two groups were compared. Results: The total effective rate of treatment and the incidence of adverse reactions in the treatment group were significantly better than those in the control group. Conclusion: For patients with chronic atrophic gastritis, the combination of amoxicillin and pectin bismuth can significantly improve the clinical symptoms of patients, improve clinical efficacy and reduce the incidence of adverse reactions, which deserves clinical application.